Search
for
Sort by
Research 781–810 of 783
- Evaluation of Surface Structure and Morphological Phenomena of Caucasian Virgin Hair with Atomic Force Microscopy
- 612 Wnt signaling induces fibrotic fat loss via DPP4 in skin fibrosis
- Autoimmune Diseases and Acquired Von Willebrand Disease in Two Cases of Progeria
- Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy
- FERTILITY-SPARING MANAGEMENT OF ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA & ENDOMETRIAL CANCER: A COMPARISON OF THE LEVONORGESTREL-RELEASING INTRAUTERINE DEVICE VS SYSTEMIC THERAPY
- Side effects of androgen deprivation therapy: monitoring and minimizing toxicity
- Endocrinological evaluation and hormonal therapy for women with difficult acne
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Hutchinson-Gilford Progeria Syndrome—Current Status and Prospects for Gene Therapy Treatment
- Contemporary medical therapy for polycystic ovary syndrome
- Workup and Management of Polycystic Ovary Syndrome
- Hormonal contraceptives: pharmacology tailored to women's health
- Management of CAH during pregnancy
- Recommendations of endocrine treatment for patients with gender dysphoria
- Balancing Hormones and Skin Health: A Focus on Oral Contraceptives in Dermatology
- Steroid Hormones of Reproduction and Sexual Development
- Feline Symmetrical Alopecia
- Pharmacology of different progestogens: the special case of drospirenone
- Androgen excess: Investigations and management
- Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Hair Loss
- Endocrine Aspects of Female Sexual Dysfunction
- Current evaluation of amenorrhea
- Androgens and Antiandrogens
- New onset of alopecia in a young woman with end-stage renal disease
- The challenging role of antiandrogens in the management of polycystic ovary syndrome
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Abstract 152
- Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.
- Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis
- Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells